학술논문
THU-162-The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets
Document Type
Abstract
Author
Merat, Shahin; Sharifi, Amir-Houshang; Shayesteh, Ali Akbar; Minakari, Mohammad; Fattahi, Mohammad Reza; Moini, Maryam; Roozbeh, Fatemeh; Mansour-Ghanaei, Fariborz; Afshar, Behrooz; Mokhtare, Marjan; Amiriani, Taghi; Sofian, Masomeh; Somi, Mohammad-Hossein; Agah, Shahram; Maleki, Iradj; Latifnia, Maryam; Hormati, Ahmad; Khoshnia, Masoud; Sohrabi, Masoud; Malekzadeh, Reza
Source
In Journal of Hepatology April 2019 70(1) Supplement:e233-e233
Subject
Language
ISSN
0168-8278